Search Results | Blood | American Society of Hematology

1-20 of 32

Sort by

Sort Order Select

Journal Articles

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Treated with DA-EPOCH-R Induction and Nivolumab Consolidation Treatment: Interim Results of the HOVON-152 Phase II Trial

A. Vera de Jonge, Erik D. van Werkhoven, Marcel Nijland, Koen de Heer, Marjolein W.M. Van Der Poel, Yorick Sandberg, Clara Klerk, Esther E.E. Drees, Margaretha GM Roemer, Daphne de Jong, D. Michiel Pegtel, Bronno van der Holt, Tuna Mutis, Josée M Zijlstra, Marie José Kersten, Martine E.D Chamuleau

Blood (2021) 138 (Supplement 1): 1414.

DOI: https://doi.org/10.1182/blood-2021-146812

Published: 2021

Journal Articles

Combining PET Radiomic Features with MYC Gene Rearrangement Results in High Prediction of Outcome in Diffuse Large B-Cell Lymphoma

Jakoba J Eertink, Gerben J.C Zwezerijnen, Sanne E Wiegers, Martine E.D Chamuleau, Pieternella Lugtenburg, Daphne De Jong, Bauke Ylstra, Matias Mendeville, Ulrich Dührsen, Andreas Hüttmann, Christine Schmitz, Julia Richter, Wolfram Klapper, Otto S Hoekstra, Henrica C.W de Vet, Ronald Boellaard, Josée M Zijlstra

Blood (2021) 138 (Supplement 1): 451.

DOI: https://doi.org/10.1182/blood-2021-145855

Published: 2021

Journal Articles

Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma

G. Tjitske Los-de Vries, Mintsje de Boer, Erik van Dijk, Phylicia Stathi, Nathalie J. Hijmering, Margaretha G. M. Roemer, Matias Mendeville, Daniel M. Miedema, Jan Paul de Boer, Hinne A. Rakhorst, Flora E. van Leeuwen, René R. W. J. van der Hulst, Bauke Ylstra, Daphne de Jong

Blood (2020) 136 (25): 2927–2932.

DOI: https://doi.org/10.1182/blood.2020005372

Published: 2020

Includes: Supplemental data

Journal Articles

Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast

Mintsje de Boer, Michael Hauptmann, Nathalie J. Hijmering, Carel J. M. van Noesel, Hinne A. Rakhorst, Hanne E. J. Meijers-Heijboer, Jan Paul de Boer, René R. W. J. van der Hulst, Daphne de Jong, Flora E. van Leeuwen

Blood (2020) 136 (11): 1368–1372.

DOI: https://doi.org/10.1182/blood.2019004498

Published: 2020

Includes: Supplemental data

Journal Articles

Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo , Irrespective of Prior Treatment with CD20 Monoclonal Antibodies

Hilma J Van Der Horst, MSc, A. Vera de Jonge, Ida H Hiemstra, PhD, Anne T Gelderloos, MSc, Daniella RAI Berry, Nathalie J Hijmering, Daphne de Jong, Prof Dr, Martine E.D. Chamuleau, Sonja Zweegman, MD PhD, Esther CW Breij, DPhil, Margaretha GM Roemer, PhD, Tuna Mutis

Blood (2019) 134 (Supplement_1): 4066.

DOI: https://doi.org/10.1182/blood-2019-125765

Published: 2019

Journal Articles

High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

Blood (2019) 134 (12): 946–950.

DOI: https://doi.org/10.1182/blood.2019001185

Published: 2019

Includes: Supplemental data

Journal Articles

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 − mantle cell lymphoma

Blood (2019) 133 (9): 940–951.

DOI: https://doi.org/10.1182/blood-2018-07-862151

Published: 2019

Includes: Supplemental data

Journal Articles

Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma

Matias Mendeville, Margaretha G. M. Roemer, Mari F. C. M. van den Hout, G. Tjitske Los-de Vries, Reno Bladergroen, Phylicia Stathi, Nathalie J. Hijmering, Andreas Rosenwald, Bauke Ylstra, Daphne de Jong

Blood (2019) 133 (4): 377–380.

DOI: https://doi.org/10.1182/blood-2017-12-822171

Published: 2019

Includes: Supplemental data

Journal Articles

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Martine E.D. Chamuleau, MD, Marcel Nijland, MD, Josée M Zijlstra, MD, Rogier Mous, MD PhD, P.J. Lugtenburg, Daan Dierickx, MD PhD, Gustaaf van Imhoff, MD PhD, Joost Vermaat, MD PhD, Katerina Bakunina, Erik W.A. Marijt, MD, Otto Visser, MDPhD, Caroline Mandigers, MD, Yavuz Bilgin, MDPhD, Coreline Burggraaff, Otto Hoekstra, MDPhD, Daphne de Jong, Prof Dr, Marie José Kersten, MD

Blood (2018) 132 (Supplement 1): 786.

DOI: https://doi.org/10.1182/blood-2018-99-110240

Published: 2018

Journal Articles

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

Yasodha Natkunam, Dita Gratzinger, Amy Chadburn, John R. Goodlad, John K. C. Chan, Jonathan Said, Elaine S. Jaffe, Daphne de Jong

Blood (2018) 132 (18): 1871–1878.

DOI: https://doi.org/10.1182/blood-2018-04-842559

Published: 2018

Journal Articles

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

Blood (2018) 131 (18): 2086–2089.

DOI: https://doi.org/10.1182/blood-2017-12-822817

Published: 2018

Includes: Supplemental data

Journal Articles

First Report on a Successful Screening Program for MYC Rearrangements and a Prospective Clinical Trial Based on MYC Rearrangement in Newly Diagnosed DLBCL Patients in the Netherlands

Martine Chamuleau, MD PhD, Marcel Nijland, MD, Niek Lamers, Nathalie Hijmering, Dana Chitu, Josée Zijlstra, MD, Otto Visser, MDPhD, Josephine M. Vos, MD, Henriette Berenschot, MD, Rinske Boersma, MD, Marie Jose Kersten, MD PhD, Daphne de Jong, Prof Dr

Blood (2017) 130 (Supplement 1): 4144.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.4144.4144

Published: 2017

Journal Articles

Effect of Rituximab in Primary Central Nervous System Lymphoma - results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study

Jacoline Bromberg, MD, Samar Issa, FRACP, Katerina Bukanina, Monique C Minnema, Tatjana Seute, MD, Marc Durian, MD, Gavin Cull, MB, BS, FRACP, FRCPA, Harry C. Schouten, MD, Wendy B Stevens, MD, Josée Zijlstra, MD, Johanna W. Baars, MD PhD, Marcel Nijland, MD, Kylie Mason, MBBS,PhDFRACP,FRCPA, Aart Beeker, MD, Martin van den Bent, MD, Daphne de Jong, Prof Dr, Michael Anthony Gonzales, BSc, Jeanette K. Doorduijn, MD PhD

Blood (2017) 130 (Supplement 1): 582.

DOI: https://doi.org/10.1182/blood.V130.Suppl_1.582.582

Published: 2017

Journal Articles

Targetable genetic features of primary testicular and primary central nervous system lymphomas

Blood (2016) 127 (7): 869–881.

DOI: https://doi.org/10.1182/blood-2015-10-673236

Published: 2016

Includes: Supplemental data

Journal Articles

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Margaretha GM Roemer, MS, Ranjana H Advani, MD, Azra H. Ligon, PhD, Yasodha Natkunam, MD PhD, Robert A Redd, MS, Heather Homer, Courtney Connelly, Heather H. Sun, Sarah E. Daadi, Bjoern Chapuy, MD PhD, Daphne de Jong, MD PhD, Richard T. Hoppe, MD, Donna S Neuberg, ScD, Scott J Rodig, MD PhD, Margaret A. Shipp, MD

Blood (2015) 126 (23): 176.

DOI: https://doi.org/10.1182/blood.V126.23.176.176

Published: 2015

Journal Articles

Actionable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas

Blood (2014) 124 (21): 74.

DOI: https://doi.org/10.1182/blood.V124.21.74.74

Published: 2014

Journal Articles

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

Blood (2011) 117 (26): 7070–7078.

DOI: https://doi.org/10.1182/blood-2011-04-345256

Published: 2011

Includes: Supplemental data

Journal Articles

MicroRNAs Specific for Immune-Privileged Diffuse Large B-Cell Lymphoma.

JanLukas Robertus, MD, Geert Harms, MSc, Tjasso Blokzijl, MSc, Daphne de Jong, MD PhD, Marije Booman, Ir, Stefano Rosati, MD, Ed Schuuring, PhD, Philip M. Kluin, MD PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 1566.

DOI: https://doi.org/10.1182/blood.V110.11.1566.1566

Published: 2007

Journal Articles

Differences in the C13orf25 miRNA Cluster in Non-Hodgkin Lymphoma and Normal B-Cell Subtypes.

Jan-Lukas Robertus, MD, Miao Wang, MD, Geert Harms, MSc, Tjasso Blokzijl, MSc, Rikst Nynke Schakel, MSc, Daphne de Jong, MD PhD, Rogier M. Reijmers, MSc, Steven T. Pals, MD PhD, Stefano Rosati, MD, Ed Schuuring, PhD, Philip M. Kluin, MD PhD, Anke van den Berg, PhD

Blood (2007) 110 (11): 3586.

DOI: https://doi.org/10.1182/blood.V110.11.3586.3586

Published: 2007

Journal Articles

In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma

Laurent Knoops, Rick Haas, Sanne de Kemp, Donné Majoor, Annegien Broeks, Eric Eldering, Jan Paul de Boer, Marcel Verheij, Conny van Ostrom, Annemieke de Vries, Laura van't Veer, Daphne de Jong

Blood (2007) 110 (4): 1116–1122.

DOI: https://doi.org/10.1182/blood-2007-01-067579

Published: 2007

Includes: Supplemental data

NARROW

High Grade B Cell Lymphoma with MYC and BCL2 and/or BCL6 Rearrangements Treated with DA-EPOCH-R Induction and Nivolumab Consolidation Treatment: Interim Results of the HOVON-152 Phase II Trial

Combining PET Radiomic Features with MYC Gene Rearrangement Results in High Prediction of Outcome in Diffuse Large B-Cell Lymphoma

Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma

Increased prevalence of BRCA1/2 mutations in women with macrotextured breast implants and anaplastic large cell lymphoma of the breast

Duobody-CD3xCD20 Induces Potent Anti-Tumor Activity in Malignant Lymph Node B Cells from Patients with DLBCL, FL and MCL Ex Vivo , Irrespective of Prior Treatment with CD20 Monoclonal Antibodies

High frequency of inactivating tetraspanin C D37 mutations in diffuse large B-cell lymphoma at immune-privileged sites

CCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1 − mantle cell lymphoma

Aggressive genomic features in clinically indolent primary HHV8-negative effusion-based lymphoma

Successful Treatment of MYC rearrangement Positive Large B Cell Lymphoma Patients with R-CHOP21 Plus Lenalidomide: Results of a Multicenter Phase II HOVON Trial

Immunodeficiency-associated lymphoproliferative disorders: time for reappraisal?

High prevalence of MYD88 and CD79B mutations in intravascular large B-cell lymphoma

First Report on a Successful Screening Program for MYC Rearrangements and a Prospective Clinical Trial Based on MYC Rearrangement in Newly Diagnosed DLBCL Patients in the Netherlands

Effect of Rituximab in Primary Central Nervous System Lymphoma - results of the Randomized Phase III HOVON 105/ALLG NHL 24 Study

Targetable genetic features of primary testicular and primary central nervous system lymphomas

PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome

Actionable Genetic Features of Primary Testicular and Primary Central Nervous System Lymphomas

Prognostic significance of immunohistochemical biomarkers in diffuse large B-cell lymphoma: a study from the Lunenburg Lymphoma Biomarker Consortium

MicroRNAs Specific for Immune-Privileged Diffuse Large B-Cell Lymphoma.

Differences in the C13orf25 miRNA Cluster in Non-Hodgkin Lymphoma and Normal B-Cell Subtypes.

In vivo p53 response and immune reaction underlie highly effective low-dose radiotherapy in follicular lymphoma

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only